Chrome Extension
WeChat Mini Program
Use on ChatGLM

Clinical development of efanesoctocog alfa (bivv001), a new class of factor viii (fviii) replacement therapy designed to provide high sustained factor activity

AMERICAN JOURNAL OF HEMATOLOGY(2023)

Cited 0|Views15
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined